Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2025-12-19 00:00:00 ET · period of report 2025-12-18 · accession 0001193125-25-327135 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-19 | 2025-12-18 | PHAT | Breedlove Robert Charles | Principal Accounting Off | F - Tax | $16.28 | -230 | 47.8K | -0.5% | -$3,744 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-18 | F | D | 230 | $16.28 | 47,844 | D | — | — |